GSK PLC earnings
Annual earnings per share (GBP per share, as reported)
| Fiscal year | Period end | Diluted EPS | Basic EPS | Filed |
|---|---|---|---|---|
| 2025 | 2025-12-31 | £1.39 | £1.41 | 2026-06-19T15:04:19Z |
| 2024 | 2024-12-31 | £0.62 | £0.63 | 2026-06-19T15:04:19Z |
| 2023 | 2023-12-31 | £1.20 | £1.22 | 2026-06-19T15:04:19Z |
Revenue & profit (GBP)
| Concept | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | — | — | — |
| Profit for the year | £6.29B | £2.95B | £5.31B |
Methodology
Earnings per share comes from ifrs-full:DilutedEarningsLossPerShare /
ifrs-full:BasicEarningsLossPerShare; revenue from
ifrs-full:Revenue and profit from ifrs-full:ProfitLoss,
as tagged in GSK PLC's ESEF annual reports (source:
filings.xbrl.org).
Figures are in GBP, as reported. Not investment advice.